Sponsors
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Blog
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?25 May 2011
White Papers
Focus Area: Drug Discovery
Changing Times
Wyeth’s Thorir Bjornsson talks to NGP about dealing with attrition, the fallout from the merger with Pfizer, and what the future holds for the industry.
Increasing R&D Efficiency from the Bench Up: A Strategic Look at Simplifying Laboratory Operations
By Restek Corporation. Today’s economic climate seems to be more than just a normal cyclical downturn, such as those the industry has experienced in the past.
Abuse Liability Testing: Safety versus Drug Control Requirements
By MPI Research. The international community has long recognized the danger involved in the manufacture, distribution, and use of certain psychoactive substances for nonscientific and/or nonmedical purposes.
Smarter Laboratory Asset Management Strategies
Masao Moriyama of GE Healthcare explains how using a single provider for the management of laboratory equipment throughout its entire lifecycle reduces administration, improves efficiency, and provides critical data to help optimize resources.
Single-use Sensors for Upstream Applications
By Finesse. One of the largest factors limiting the proliferation of single-use bioreactors in cGMP and production environments is the lack of reliable and well engineered single-use sensors.
Source: www.ngpharma.com© 2012 GDS Publishing Ltd. All rights reserved.